BusinessGujarat Themis Secures $58M Private Credit for Japanese Acquisition
Indian drugmaker Gujarat Themis Biosyn Ltd. secured ¥9.2 billion ($58 million) in private credit from Asian fund Orion Capital Asia to finance its acquisition of Japanese company MicroBiopharm Japan Co. The ¥21.5 billion purchase was announced in May. This deal highlights the rising trend of Asian firms using private credit for faster overseas expansion.
Business Standard·1d ago



